A0A2R9A7H9 (A0A2R9A7H9_PANPA) Pan paniscus (Pygmy chimpanzee) (Bonobo)
Caspase-3 UniProtKBInterProSTRINGInteractive Modelling
277 aa; Sequence (Fasta) ;
1 identical sequence: Homo sapiens: P42574
It is possible new templates exist for this target since these models were created.
Available Structures
135 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Human caspase-3 in complex with Ac-ATS009-KE |
Heteromer P42574; | 100 | ||||
| Human caspase-3 in complex with Ac-DW3-KE |
Heteromer P42574; | 100 | ||||
| Caspase-3:CAS329306 |
Heteromer P42574; | 100 | 2×TQ8; | |||
| Crystal structures of caspase-3 in complex with aza-peptide epoxide inhibitors. |
Heteromer P42574; | 100 | ||||
| Crystal structure of caspase-3 with inhibitor Ac-DEVD-Cho |
Heteromer P42574; | 100 | ||||
| Crystal structures of caspase-3 in complex with aza-peptide epoxide inhibitors. |
Heteromer P42574; | 100 | ||||
| Crystal structures of caspase-3 in complex with aza-peptide epoxide inhibitors. |
Heteromer P42574; | 100 | ||||
| Crystal structures of caspase-3 in complex with aza-peptide Michael acceptor inhibitors. |
Heteromer P42574; | 100 | ||||
| Caspase-3:CAS26049945 |
Heteromer P42574; | 100 | 2×XVE; | |||
| Crystal structures of caspase-3 in complex with aza-peptide Michael acceptor inhibitors. |
Heteromer P42574; | 100 | ||||
| Caspase-3:CAS60254719 |
Heteromer P42574; | 100 | 2×TQ9; | |||
| Crystal structures of caspase-3 in complex with aza-peptide Michael acceptor inhibitors. |
Heteromer P42574; | 100 | ||||
| Crystal structures of caspase-3 in complex with aza-peptide Michael acceptor inhibitors. |
Heteromer P42574; | 100 | ||||
| THE 2.8 ANGSTROM CRYSTAL STRUCTURE OF CASPASE-3 (APOPAIN OR CPP32)IN COMPLEX WITH AN ISATIN SULFONA… |
Heteromer P42574; | 100 | 1×MSI; | |||
| CRYSTAL STRUCTURE OF THE COMPLEX OF XIAP-BIR2 AND CASPASE 3 |
Heteromer P42574; P98170; | 99.3 | 2×ZN; | |||
| Crystal Structure of Caspase-3 with Peptide Inhibitor Ac-VDV(DAB)D-CHO |
Heteromer P42574; | 100 | ||||
| Crystal structure of caspase-3 with inhibitor Ac-VDFVD-CHO |
Heteromer P42574; | 100 | ||||
| Crystal Structure of caspase 3, L168Y mutant |
Heteromer P42574; | 99.29 | ||||
| Crystal Structure of caspase 3, L168F mutant |
Heteromer P42574; | 99.29 | ||||
| Crystal structure of caspase 3, L168D mutant |
Heteromer P42574; | 99.29 | ||||
| Crystal structure of caspase-3 with inhibitor Ac-VDRVD-CHO |
Heteromer P42574; | 100 | ||||
| Crystal structure of caspase-3 with inhibitor Ac-VD(Orn)VD-CHO |
Heteromer P42574; | 100 | ||||
| Caspase-3 Binds Diverse P4 Residues in Peptides |
Heteromer P42574; | 100 | ||||
| Crystal structure of caspase-3 with inhibitor Ac-ITV(Dab)D-CHO |
Heteromer P42574; | 100 | ||||
| Crystal structure of caspase-3 with inhibitor Ac-VDVVD-CHO |
Heteromer P42574; | 100 | ||||
| Crystal structure of Caspase 3 S150A |
Heteromer P42574; | 99.29 | 1×CL; 2×AZI; | |||
| Crystal strusture of caspase-3 with inhibitor Ac-DMQD-Cho |
Heteromer P42574; | 100 | ||||
| Caspase-3 in Complex with an Inhibitory DARPin-3.4 |
Heteromer P42574; | 100 | 1×MRD; 1×MPD; | |||
| Caspase-3 in Complex with an Inhibitory DARPin-3.4_S76R |
Heteromer P42574; | 100 | 2×MPD; 1×MRD; | |||
| Crystal structure of caspase-3 with inhibitor Ac-VDKVD-CHO |
Heteromer P42574; | 100 | ||||
| Caspase-3 Binds Diverse P4 Residues in Peptides |
Heteromer P42574; | 100 | 1×DZE; 1×GOL; | |||
| Crystal strusture of caspase-3 with inhibitor Ac-VDVAD-Cho |
Heteromer P42574; | 100 | ||||
| Caspase-3 in Complex with DARPin-3.4_I78S |
Heteromer P42574; | 100 | 2×MRD; | |||
| Crystal Structure of Caspase-3 with Peptide Inhibitor AcITV(Orn)D-CHO |
Heteromer P42574; | 100 | ||||
| Crystal structure of caspase-3 with inhibitor Ac-VDPVD-CHO |
Heteromer P42574; | 100 | ||||
| Caspase-3 Binds Diverse P4 Residues in Peptides |
Heteromer P42574; | 100 | ||||
| Crystal Structure of Caspase-3 with Peptide Inhibitor AcITVKD-CHO |
Heteromer P42574; | 100 | ||||
| Crystal structure of caspase-3 with inhibitor Ac-VD(Aly)VD-CHO |
Heteromer P42574; | 100 | ||||
| Caspase-3 Binds Diverse P4 Residues in Peptides |
Heteromer P42574; | 100 | ||||
| Crystal Structure of Caspase-3 with Peptide Inhibitor AcDVPD-CHO |
Heteromer P42574; | 100 | ||||
| Crystal structure of caspase-3 with inhibitor Ac-YKPVD-CHO |
Heteromer P42574; | 100 | ||||
| Crystal structure of caspase-3 with inhibitor Ac-ITAKD-CHO |
Heteromer P42574; | 100 | ||||
| Crystal structure of caspase-3 DEVE peptide complex |
Heteromer P42574; | 100 | ||||
| Cryo-EM structure of CopC-CaM-caspase-3 with NAD+ |
Heteromer P0DP23; P42574; Q7NWF2; | 100.0 | 1×NAD; | |||
| Cryo-EM structure of CopC-CaM-caspase-3 with ADPR-deacylization |
Heteromer P0DP23; P42574; Q7NWF2; | 100.0 | 1×NCA; | |||
| Cryo-EM structure of CopC-CaM-caspase-3 with ADPR |
Heteromer P0DP23; P42574; Q7NWF2; | 100.0 | 1×NCA; 1×APR; | |||
| Extended substrate recognition in caspase-3 revealed by high resolution X-ray structure analysis | homo-4-mer | 100 | ||||
| The Role of Loop Bundle Hydrogen Bonds in the Maturation and Activity of(Pro)caspase-3 | homo-4-mer | 99.58 | ||||
| The Role of Loop Bundle Hydrogen Bonds in the Maturation and Activity of (Pro)caspase-3 | homo-4-mer | 100.0 | ||||
| The Role of Loop Bundle Hydrogen Bonds in the Maturation and Activity of(Pro)caspase-3 | homo-4-mer | 99.58 | ||||
| Crystal structure of Pseudo-activated Procaspase-3 | homo-4-mer | 99.58 | ||||
| Extended substrate recognition in caspase-3 revealed by high resolution X-ray structure analysis | homo-4-mer | 100 | ||||
| Extended substrate recognition in caspase-3 revealed by high resolution X-ray structure analysis | homo-4-mer | 100 | ||||
| Crystal structures of caspase-3 in complex with aza-peptide epoxide inhibitors. | homo-4-mer | 100 | ||||
| Crystal structures of caspase-3 in complex with aza-peptide epoxide inhibitors. | homo-4-mer | 100 | ||||
| The Role of Loop Bundle Hydrogen Bonds in the Maturation and Activity of (Pro)caspase-3 | homo-4-mer | 99.57 | ||||
| Caspase-3 in complex with ketomethylene inhibitor reveals tetrahedral adduct | homo-4-mer | 100 | ||||
| Crystal structure of Caspase-3 with inhibitor AC-LDESD-CHO | homo-4-mer | 100 | ||||
| Caspase 3 Bound to a covalent inhibitor | homo-4-mer | 100 | 2×B92; | |||
| CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A PRYAZINONE INHIBITOR | homo-4-mer | 100 | 2×PZN; | |||
| CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A NICOTINIC ACID ALDEHYDE INHIBITOR | homo-4-mer | 100 | 2×NA4; | |||
| CRYSTAL STRUCTURE OF CASPASE-3 WITH A NICOTINIC ACID ALDEHYDE INHIBITOR | homo-4-mer | 100 | 2×NA3; | |||
| Crystal structure of the complex of caspase-3 with a phenyl-propyl-ketone inhibitor | homo-4-mer | 100 | ||||
| CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A 5,6,7 TRICYCLIC PEPTIDOMIMETIC INHIBITOR | homo-4-mer | 100 | 2×3CY; | |||
| CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A BROMOMETHOXYPHENYL INHIBITOR | homo-4-mer | 100 | 2×0ZZ; | |||
| CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A CINNAMIC ACID METHYL ESTER INHIBITOR | homo-4-mer | 100 | 2×CNE; | |||
| Caspase-3 in complex with elongated ketomethylene inhibitor | homo-4-mer | 100 | ||||
| Caspase 3 V266M | homo-2-mer | 99.58 | 4×AZI; | |||
| Caspase-3 T140GV266H | homo-2-mer | 99.16 | 2×NA; 4×AZI; 2×MPD; | |||
| Caspase 3 V266Y | homo-2-mer | 99.58 | 2×NA; | |||
| Caspase-3 Mutant- T245D | homo-2-mer | 100 | 11×NA; 2×AZI; | |||
| Caspase-3 Mutant - T245D,S249D | homo-2-mer | 100 | 1×AZI; | |||
| Caspase 3 V266F | homo-2-mer | 99.58 | 2×CL; 1×ACT; | |||
| Caspase-3 F128A | homo-2-mer | 99.58 | 12×AZI; | |||
| Caspase 3 V266L | homo-2-mer | 99.57 | 2×NA; | |||
| Structure of Casp-3 with tethered salicylate | homo-2-mer | 100 | 1×158; 1×159; | |||
| Caspase-3 Mutant - S150Y | homo-2-mer | 99.31 | ||||
| Caspase-3 E190A | homo-2-mer | 99.58 | 2×NA; 2×AZI; | |||
| Caspase-3 Mutant - T152V | homo-2-mer | 99.31 | ||||
| Caspase 3 V266I | homo-2-mer | 99.58 | 2×NA; | |||
| Caspase-3 K137A | homo-2-mer | 99.58 | 10×AZI; | |||
| Caspase-3 M61A V266H | homo-2-mer | 99.16 | 2×CL; 2×DTT; | |||
| Caspase-3 Mutant- T245A | homo-2-mer | 100 | 3×NA; | |||
| Caspase-3 F128AV266H | homo-2-mer | 99.19 | 2×DTT; 2×CL; | |||
| Caspase 3 V266W | homo-2-mer | 99.58 | 2×NA; 2×DTT; | |||
| Caspase 3 V266A | homo-2-mer | 99.58 | 2×NA; | |||
| Caspase 3 V266S | homo-2-mer | 99.58 | 2×NA; | |||
| Caspase-3 Mutant- D9A,D28A,T152D | homo-2-mer | 99.31 | 2×CL; 1×AZI; | |||
| Caspase-3 Mutant - D9A,D28A,S150E | homo-2-mer | 99.31 | 1×NA; | |||
| Caspase-3 Y195F | homo-2-mer | 99.58 | ||||
| Caspase-3 F55W | homo-2-mer | 99.56 | 3×AZI; | |||
| Caspase-3 T140V | homo-2-mer | 99.58 | ||||
| Caspase-3 Mutant - T152A | homo-2-mer | 99.31 | 3×NA; 1×CL; | |||
| Caspase 3 V266C | homo-2-mer | 99.58 | 1×ACT; | |||
| Caspase-3 Y195AV266H | homo-2-mer | 99.16 | 2×AZI; | |||
| Caspase-3 Mutant - S150D | homo-2-mer | 99.31 | 1×CL; 5×AZI; | |||
| Caspase-3 Mutant - S150E | homo-2-mer | 99.31 | 4×AZI; | |||
| Caspase 3 V266N | homo-2-mer | 99.58 | 2×NA; | |||
| Caspase-3 Y195A | homo-2-mer | 99.58 | 2×ACT; | |||
| Caspase-3 T140F | homo-2-mer | 99.58 | ||||
| Crystal Structures of Caspase-3 with Bound Isoquinoline-1,3,4-trione Derivative Inhibitors | homo-2-mer | 99.57 | ||||
| Caspase-3 tethered to irreversible inhibitor | homo-2-mer | 99.58 | 2×161; | |||
| Caspase 3 V266K | homo-2-mer | 99.56 | ||||
| Caspase 3 V266D | homo-2-mer | 99.57 | 1×DTT; | |||
| Human procaspase-3 bound to Ac-DEVD-CMK | homo-2-mer | 100.0 | 2×CL; | |||
| Caspase-3 Mutant- D9A,D28A,T245D | homo-2-mer | 100 | 1×AZI; | |||
| Caspase-3 Mutant - D9A,D28A,S150D | homo-2-mer | 99.29 | 1×NA; 2×AZI; | |||
| Crystal Structures of Caspase-3 with Bound Isoquinoline-1,3,4-trione Derivative Inhibitors | homo-2-mer | 99.57 | 1×RXD; | |||
| Extendend Tethering: In Situ Assembly of Inhibitors | homo-2-mer | 99.58 | 2×160; | |||
| Human procaspase-3, crystal form 1 | homo-2-mer | 99.48 | ||||
| Crystal Structures of Caspase-3 with Bound Isoquinoline-1,3,4-trione Derivative Inhibitors | homo-2-mer | 99.57 | ||||
| Crystal Structures of Caspase-3 with Bound Isoquinoline-1,3,4-trione Derivative Inhibitors | homo-2-mer | 99.57 | ||||
| Human procaspase-3, crystal form 2 | homo-2-mer | 99.49 | ||||
| Caspase-3 T140G | homo-2-mer | 99.57 | 2×MRD; 4×AZI; 1×DTT; | |||
| Caspase-3 Y195FV266H | homo-2-mer | 99.14 | 1×DTT; 2×AZI; | |||
| Caspase-3 Mutant- T152D | homo-2-mer | 99.29 | 5×NA; 1×CL; 1×AZI; | |||
| Conformational restrictions in the active site of unliganded human caspase-3 | homo-2-mer | 99.57 | ||||
| Caspase-3 M61A | homo-2-mer | 99.57 | 1×CL; 1×ACT; 3×AZI; | |||
| 3,4-Dihydropyrimido(1,2-a)indol-10(2H)-ones as Potent Non-Peptidic Inhibitors of Caspase-3 | homo-2-mer | 100.0 | 2×H0E; | |||
| CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE TETRAPEPTIDE INHIBITOR ACE-DVAD-FMC | homo-2-mer | 99.57 | ||||
| Crystal structure of the complex of apopain with the tetrapeptide aldehyde inhibitor AC-DEVD-CHO | homo-2-mer | 100 | ||||
| Caspase-3 specific unnatural amino acid peptides | monomer | 100.0 | ||||
| Caspase-3 E246A, K242A Double Mutant | monomer | 99.18 | ||||
| Allosteric Modulation of Caspase-3 through Mutagenesis | monomer | 99.58 | ||||
| Allosteric Modulation of Caspase-3 through Mutagenesis | monomer | 99.17 | ||||
| Caspase-8 specific unnatural amino acid peptides | monomer | 100.0 | ||||
| Caspase 3 V266Q | monomer | 99.58 | ||||
| Caspase-3 E246A | monomer | 99.16 | 1×CL; | |||
| Caspase-3 K242A | monomer | 99.58 | ||||
| Allosteric Modulation of Caspase-3 through Mutagenesis | monomer | 99.57 | ||||
| Caspase-8 specific unnatural amino acid peptides | monomer | 100.0 | ||||
| Allosteric Modulation of Caspase-3 through Mutagenesis | monomer | 98.71 | ||||
| Allosteric Modulation of Caspase-3 through Mutagenesis | monomer | 99.14 | ||||
| Allosteric Modulation of Caspase-3 through Mutagenesis | monomer | 99.57 | ||||
| Allosteric Modulation of Caspase-3 through Mutagenesis | monomer | 99.13 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5ibc.1.B | homo-2-mer | 0.80 | 2×ACE; | 99.64 | ||